Journal articleRedox Biol2025
The absence of Peroxiredoxin-1 in human pancreatic ductal adenocarcinoma (PDAC) markedly reduces cell survival and tumor growth when coupled with the inhibition of Ref-1 redox signaling.
- Journal
- Redox Biol
- Published
- 2 September 2025
- Citations
- 6
- Type
- Article
- License
- cc by-nc
These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Grants 4
- Cancer Prevention and Control P30CA082709↗
- Exploiting the Ref-1 node in pancreatic cancer: tailoring new pancreatic cancer therapy using multi-targeted combinatio… R01CA167291↗
- Investigation of novel signaling protein in 3D and in vivo PDAC models using second generation Ref-1 inhibitors R01CA254110↗
- Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox si… R01CA282478↗